Kabeer Aziz

Insider Reports History

Entity
Individual
Location
376 Manhattan Avenue Apt. 3, Brooklyn, NY
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Kabeer Aziz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kabeer Aziz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Common Stock 2M $38.2M $19.11 Jan 16, 2024 By Adjuvant Global Health Technology Fund, L.P.
AN2 Therapeutics, Inc. Director Common Stock 378K $7.22M $19.11 Jan 16, 2024 By Adjuvant Global Health Technology Fund DE, L.P.
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 64.5K Jun 19, 2024 Direct

Insider Reports Filed by Kabeer Aziz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ANTX AN2 Therapeutics, Inc. Jun 19, 2024 1 $0 4 Jun 21, 2024 Director
ANTX AN2 Therapeutics, Inc. Jan 16, 2024 2 -$1.97M 4 Jan 18, 2024 Director
ANTX AN2 Therapeutics, Inc. Nov 14, 2023 2 -$29.2K 4 Nov 16, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 29, 2023 4 -$1.7M 4 Oct 3, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Sep 27, 2023 4 -$151K 4 Sep 29, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Sep 15, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 4 -$114K 4 Sep 8, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Aug 23, 2023 2 -$6.4K 4 Aug 25, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Jun 6, 2022 2 $0 4 Jun 24, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ANTX AN2 Therapeutics, Inc. Mar 29, 2022 9 $2.5M 4 Mar 31, 2022 Director, 10%+ Owner
ANTX AN2 Therapeutics, Inc. Mar 24, 2022 0 $0 3 Mar 24, 2022 Director